Skip to main content
CancerGeneticsDiagnostics and screeningProcedureDiagnostic test

What this study is

Study goal is to collect tumor specimens that may inform cancer biology to eventually improve outcomes for patients with cancer. This proposal represents a highly collaborative effort to support cancer research with the goal of developing novel therapeutic strategies using patient derived preclinical models.

This study is being done to collect samples of tumor tissues, matched normal tissue when possible, and approximately 50 mL of blood.

What's being tested

  • Tissue Collection

    Intervention · PROCEDURE

    Research tissue specimen will be obtained during the patient's clinical biopsy or clinical tumor resection, if feasible.

  • Blood Collection

    Intervention · DIAGNOSTIC TEST

    Up to 50 mL of research blood will be drawn around the time of the procedure. Additional blood may be collected in selected cases, as warranted, to monitor disease recurrence/remission or perform additional

  • Buccal Swab

    Intervention · DIAGNOSTIC TEST

    Buccal swab may be requested, if necessary, to generate germline data.

Study details

Sponsor
Mayo Clinic
Conditions
Cancer
Enrolling
50 people
Starts
2022-04-06
Est. completion
2028-03-31
Record
View on ClinicalTrials.gov ↗